BGM Group Ltd. Class A Ordinary Shares (BGM)
Stock · NASDAQ · Health Care
$0.328as of 8/28/2026
Price chart
Open in TradingViewActive signals
BOLL Breakout94.0%
High Beta42.4%
Support level
$0.28475
Industry
Biotechnology: Pharmaceutical Preparations
About BGM
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetra…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.bgmgroupltd.com/
Fundamentals
- 1-day range
- $0.2721$0.33
- Market cap
- $118.62M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.13
- Dividend yield
- —
- Beta
- 1.87
- Avg. volume
- 413.9K
- Ex-dividend date
- February 27, 2023
- Dividend pay date
- March 6, 2023
52-week range
$0.2287$11.8
Next earnings: March 16, 2026
BGM Group Ltd. Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- BGMBGM Group Ltd. Class A Ordinary Shares$0.3251▲ 11.34%Market cap $118.62MP/E —$0.2287$11.8
- PMNProMIS Neurosciences Inc. Common Shares (ON)$13.79▼ 1.43%Market cap $119.54MP/E —$6.27$27.4
- GNLXGenelux Corporation Common Stock$2.66▼ 7.64%Market cap $121.07MP/E —$2.29$8.54
- IFRXInflaRx N.V. Common Stock$2.22▼ 2.20%Market cap $124.34MP/E —$0.7984$2.95
- NRXPNRX Pharmaceuticals Inc. Common Stock$3.54▼ 2.21%Market cap $111.95MP/E —
- PLYXPolaryx Therapeutics Inc. Common Stock$2.07▼ 2.13%Market cap $110.66MP/E —$1.86$48.91
- SPRBSpruce Biosciences Inc. Common Stock$60.05▼ 5.13%Market cap $127.76MP/E —$7$240
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BGM BGM Group Ltd. Class A Ordinary Shares | $118.62M | — | $0.3251 | ▲ 11.34% | $0.2287$11.8 |
| PMN ProMIS Neurosciences Inc. Common Shares (ON) | $119.54M | — | $13.79 | ▼ 1.43% | $6.27$27.4 |
| GNLX Genelux Corporation Common Stock | $121.07M | — | $2.66 | ▼ 7.64% | $2.29$8.54 |
| IFRX InflaRx N.V. Common Stock | $124.34M | — | $2.22 | ▼ 2.20% | $0.7984$2.95 |
| NRXP NRX Pharmaceuticals Inc. Common Stock | $111.95M | — | $3.54 | ▼ 2.21% | |
| PLYX Polaryx Therapeutics Inc. Common Stock | $110.66M | — | $2.07 | ▼ 2.13% | $1.86$48.91 |
| SPRB Spruce Biosciences Inc. Common Stock | $127.76M | — | $60.05 | ▼ 5.13% | $7$240 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Wondering what's happening in today's after-hours session?ChartMill · 8/28/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 7/31/2026
- BGM Group Announces Chairman And Co-CEO Chen Xin Resigns, Effective July 30, 2026; Zhanchang Xin Appointed As New Chairman Of Board; Hong Li Named As Co-Chief Executive Officerbenzinga · 7/30/2026
See the full, filterable feed with live charts on the MarketWall dashboard.